» Articles » PMID: 23424238

Left Ventricular Global Function Index by Magnetic Resonance Imaging--a Novel Marker for Assessment of Cardiac Performance for the Prediction of Cardiovascular Events: the Multi-ethnic Study of Atherosclerosis

Overview
Journal Hypertension
Date 2013 Feb 21
PMID 23424238
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Left ventricular (LV) function is generally assessed independent of structural remodeling and vice versa. The purpose of this study was to evaluate a novel LV global function index (LVGFI) that integrates LV structure with global function and to assess its predictive value for cardiovascular (CV) events throughout adult life in a multiethnic population of men and women without history of CV diseases at baseline. A total of 5004 participants in the Multi-Ethnic Study of Atherosclerosis underwent a cardiac magnetic resonance study and were followed up for a median of 7.2 years. The LVGFI by cardiac magnetic resonance was defined by the ratio of stroke volume divided by LV total volume defined as the sum of mean LV cavity and myocardial volumes. Cox proportional hazard models were constructed to predict the end points of heart failure, hard CV events, and a combined end point of all CV events after adjustment for established risk factors, calcium score, and biomarkers. A total of 579 (11.6%) CV events were observed during the follow-up period. In adjusted models, the end points of heart failure, hard CV events, and all events were all significantly associated with LVGFI (heart failure, hazard ratio=0.64, P<0.0001; hard CV events, hazard ratio=0.79, P=0.007; all events, hazard ratio=0.79, P<0.0001). LVGFI had a significant independent predictive value in the multivariable models for all CV event categories. The LVGFI was a powerful predictor of incident HF, hard CV events, and a composite end point, including all events in this multiethnic cohort.

Citing Articles

A novel index evaluating left atrioventricular coupling function in chronic kidney disease with diabetes patients.

Gao X, Xie A, Xiao W, Ji L, Li H, Zou A Sci Rep. 2025; 15(1):8402.

PMID: 40069282 PMC: 11897204. DOI: 10.1038/s41598-025-88402-9.


Assessing coronary artery stenosis exacerbated impact on left ventricular function and deformation in metabolic syndrome patients by 3.0 T cardiac magnetic resonance imaging.

Jiang Y, Gao Y, Min C, Guo Y, Xu R, Shen L Cardiovasc Diabetol. 2024; 23(1):414.

PMID: 39558352 PMC: 11575079. DOI: 10.1186/s12933-024-02492-9.


Cardiovascular magnetic resonance in β-thalassemia major: beyond T2.

Meloni A, Saba L, Cademartiri F, Positano V, Pistoia L, Cau R Radiol Med. 2024; 129(12):1812-1822.

PMID: 39511065 DOI: 10.1007/s11547-024-01916-6.


Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T cardiac magnetic resonance feature tracking study.

Tang X, Shi R, Jiang L, Yan W, Han P, Qian W Cardiovasc Diabetol. 2024; 23(1):317.

PMID: 39192259 PMC: 11350936. DOI: 10.1186/s12933-024-02410-z.


In-silico heart model phantom to validate cardiac strain imaging.

Mukherjee T, Usman M, Mehdi R, Mendiola E, Ohayon J, Lindquist D bioRxiv. 2024; .

PMID: 39149320 PMC: 11326205. DOI: 10.1101/2024.08.05.606672.


References
1.
Pfeffer M, Braunwald E, Moye L, Basta L, Brown Jr E, Cuddy T . Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992; 327(10):669-77. DOI: 10.1056/NEJM199209033271001. View

2.
Persson H, Lonn E, Edner M, Baruch L, Lang C, Morton J . Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol. 2007; 49(6):687-94. DOI: 10.1016/j.jacc.2006.08.062. View

3.
Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago J . Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation. 2002; 105(21):2512-7. DOI: 10.1161/01.cir.0000017264.66561.3d. View

4.
Baicu C, Zile M, Aurigemma G, Gaasch W . Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation. 2005; 111(18):2306-12. DOI: 10.1161/01.CIR.0000164273.57823.26. View

5.
Bild D, Bluemke D, Burke G, Detrano R, Diez Roux A, Folsom A . Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002; 156(9):871-81. DOI: 10.1093/aje/kwf113. View